Acro Biomedical (ACBM) Free Cash Flow (2015 - 2025)
Acro Biomedical (ACBM) recorded quarterly Free Cash Flow of -$25377.0 in Q4 2025, up 53.36% quarter-over-quarter from -$54410.0 in Q3 2025, and down 141.34% on a YoY basis from $61384.7 in Q4 2024.
Acro Biomedical (ACBM) Free Cash Flow (2015 - 2025) Analysis & Trends
Acro Biomedical's Free Cash Flow history runs 11 years deep, the most recent figure standing at -$25377.0 for Q4 2025.
- In Q4 2025, Free Cash Flow fell 141.34% year-over-year to -$25377.0; the TTM figure through Dec 2025 stood at -$196302.0 (down 435.0% YoY), while the FY2025 annual figure was -$196302.0, down 435.0% from the prior year.
- Free Cash Flow was -$25377.0 for Q4 2025 at Acro Biomedical, up from -$54410.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $432770.0 in Q2 2021 to a low of -$345777.0 in Q2 2022.
- Historically, Free Cash Flow has averaged -$4829.3 across 5 years, with a median of -$11590.5 in 2022.
- The sharpest annual moves came in 2022 and 2024: Free Cash Flow jumped 3228.07% in 2022, then sank 1411.59% in 2024.
- A 5-year view of Free Cash Flow shows it stood at -$60506.0 in 2021, then jumped by 82.53% to -$10568.0 in 2022, then retreated by 19.35% to -$12613.0 in 2023, then gained by 16.63% to -$10515.0 in 2024, then slumped by 141.34% to -$25377.0 in 2025.
- The last three Free Cash Flow figures came in at -$25377.0 (Q4 2025), -$54410.0 (Q3 2025), and -$93984.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | -121,028.00 |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | 10,832.00 |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | -119,667.00 |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | -334,671.00 |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | -72,157.00 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -195,797.00 |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | 1.32 Mn |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | -171,240.00 |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | -204,942.00 |
| 10 | Acro Biomedical | - | - | - | -25,377.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25,377.00 |
| Dec 31, 2025 | -25,377.00 |
| Sep 30, 2025 | -54,410.00 |
| Sep 30, 2025 | -54,410.00 |
| Jun 30, 2025 | -93,984.00 |
| Jun 30, 2025 | -93,984.00 |
| Mar 31, 2025 | -22,531.00 |
| Mar 31, 2025 | -22,531.00 |
| Dec 31, 2024 | -10,515.00 |
| Dec 31, 2024 | -10,515.00 |
| Sep 30, 2024 | -6,335.00 |
| Sep 30, 2024 | -6,335.00 |
| Jun 30, 2024 | -6,329.00 |
| Jun 30, 2024 | -6,329.00 |
| Mar 31, 2024 | -13,513.00 |
| Mar 31, 2024 | -13,513.00 |
| Dec 31, 2023 | -12,613.00 |
| Dec 31, 2023 | -12,613.00 |
| Sep 30, 2023 | 483.00 |
| Sep 30, 2023 | 483.00 |